The third edition of this important gold-standard title outlines a range of significant
advances in the study and understanding of myasthenia gravis. The overarching goal of this new
edition is identical to the first and second -- to provide the clinician and the scientist with
a common resource for understanding the profound achievements in the clinical translational
and basic sciences of neuromuscular transmission disorders. In addition to several new authors
and an extensive update of all chapters this third edition includes summaries of pre-clinical
research standards for autoimmune MG along with a broad summary of MG clinical trial
performance. The now greater understanding of the clinical presentation of MuSK-related MG and
identification of potential new autoantigens including LRP-4 is discussed. The development of
treatment guidelines by groups in Japan the United Kingdom Germany and an international
consortium is also outlined. Myasthenia Gravis and Related Disorders Third Edition is an
invaluable resource for meeting the many and varied needs of clinicians who treat patients with
myasthenia gravis.
